• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

水飞蓟宾对大鼠体内吡嗪酰胺和吡嗪酸药代动力学的影响。

Effect of silibinin on the pharmacokinetics of pyrazinamide and pyrazinoic acid in rats.

作者信息

Wu Jhy-Wen, Tsai Tung-Hu

机构信息

National Yang-Ming University, School of Medicine, Institute of Traditional Medicine, 155, Li-Nong Street Section 2, Taipei 112, Taiwan.

出版信息

Drug Metab Dispos. 2007 Sep;35(9):1603-10. doi: 10.1124/dmd.107.014894. Epub 2007 May 31.

DOI:10.1124/dmd.107.014894
PMID:17540707
Abstract

Pyrazinamide (PZA) is widely used in combination with other drugs in chemotherapy for tuberculosis. However, the dose-related liver injury is the main adverse effect of PZA and its metabolite [pyrazinoic acid (PA)]. Silibinin is the main flavonoid extracted from milk thistle (Silybum marianum), and it displays hepatoprotective properties. This study investigates the pharmacokinetics of PZA and PA and their interaction with silibinin in rats. The parallel study design was divided into six groups: PZA alone, PZA + long-term silibinin exposure, PZA + concomitant short-term silibinin exposure, PA alone, PA + long-term silibinin exposure, and PA + concomitant short-term silibinin exposure groups. The results indicate that the distribution ratio of PZA from bile to blood [area under the curve (AUC)(bile)/AUC(blood)] in the PZA + long-term silibinin exposure and PZA + concomitant short-term silibinin exposure groups was also not significantly different when compared with the PZA alone group. However, the bile-to-blood distribution ratio of PA was significantly decreased in the PA + long-term silibinin exposure and the PA + concomitant short-term silibinin exposure groups. On PZA administration, the blood, but not bile, levels of PA were markedly increased in the PZA + long-term silibinin exposure and PZA + concomitant short-term silibinin exposure groups, but the bile-to-blood ratio of PA was decreased. These results suggest that the excretion pathway of PA may be blocked by silibinin through xanthine oxidase and hepatobiliary excretion.

摘要

吡嗪酰胺(PZA)在结核病化疗中广泛与其他药物联合使用。然而,与剂量相关的肝损伤是PZA及其代谢产物[吡嗪酸(PA)]的主要不良反应。水飞蓟宾是从水飞蓟(Silybum marianum)中提取的主要黄酮类化合物,具有肝脏保护特性。本研究调查了PZA和PA在大鼠体内的药代动力学及其与水飞蓟宾的相互作用。平行研究设计分为六组:单独使用PZA组、PZA + 长期水飞蓟宾暴露组、PZA + 短期水飞蓟宾同时暴露组、单独使用PA组、PA + 长期水飞蓟宾暴露组和PA + 短期水飞蓟宾同时暴露组。结果表明,与单独使用PZA组相比,PZA + 长期水飞蓟宾暴露组和PZA + 短期水飞蓟宾同时暴露组中PZA从胆汁到血液的分布比率[曲线下面积(AUC)(胆汁)/AUC(血液)]也无显著差异。然而,在PA + 长期水飞蓟宾暴露组和PA + 短期水飞蓟宾同时暴露组中,PA的胆汁 - 血液分布比率显著降低。给予PZA后,PZA + 长期水飞蓟宾暴露组和PZA + 短期水飞蓟宾同时暴露组中PA的血液水平显著升高,但胆汁中PA水平未升高,且PA的胆汁 - 血液比率降低。这些结果表明,水飞蓟宾可能通过黄嘌呤氧化酶和肝胆排泄途径阻断PA的排泄。

相似文献

1
Effect of silibinin on the pharmacokinetics of pyrazinamide and pyrazinoic acid in rats.水飞蓟宾对大鼠体内吡嗪酰胺和吡嗪酸药代动力学的影响。
Drug Metab Dispos. 2007 Sep;35(9):1603-10. doi: 10.1124/dmd.107.014894. Epub 2007 May 31.
2
Investigation of the effects of concomitant caffeine administration on the metabolic disposition of pyrazinamide in rats.
Biopharm Drug Dispos. 2002 Jul;23(5):191-5. doi: 10.1002/bdd.305.
3
Hepatobiliary excretion of silibinin in normal and liver cirrhotic rats.水飞蓟宾在正常和肝硬化大鼠中的肝胆排泄。
Drug Metab Dispos. 2008 Mar;36(3):589-96. doi: 10.1124/dmd.107.017004. Epub 2007 Nov 29.
4
Determination of pyrazinamide and its main metabolites in rat urine by high-performance liquid chromatography.
J Chromatogr B Biomed Sci Appl. 1997 Aug 1;695(2):365-72. doi: 10.1016/s0378-4347(97)00175-8.
5
Herb-drug interaction of silymarin or silibinin on the pharmacokinetics of trazodone in rats.
Chem Biol Interact. 2009 Dec 10;182(2-3):227-32. doi: 10.1016/j.cbi.2009.09.005. Epub 2009 Sep 16.
6
A novel mechanism underlies the hepatotoxicity of pyrazinamide.一种新的机制是吡嗪酰胺肝毒性的基础。
Antimicrob Agents Chemother. 2013 Apr;57(4):1685-90. doi: 10.1128/AAC.01866-12. Epub 2013 Jan 28.
7
Metabolic disposition of pyrazinamide in the rat: identification of a novel in vivo metabolite common to both rat and human.
Biopharm Drug Dispos. 1987 Jul-Aug;8(4):307-18. doi: 10.1002/bdd.2510080402.
8
An improved LC-MS/MS method for the simultaneous determination of pyrazinamide, pyrazinoic acid and 5-hydroxy pyrazinoic acid in human plasma for a pharmacokinetic study.一种用于药代动力学研究的同时测定人血浆中吡嗪酰胺、吡嗪酸和5-羟基吡嗪酸的改进型液相色谱-串联质谱法。
J Chromatogr B Analyt Technol Biomed Life Sci. 2016 Apr 1;1017-1018:52-61. doi: 10.1016/j.jchromb.2016.02.036. Epub 2016 Feb 27.
9
High Systemic Exposure of Pyrazinoic Acid Has Limited Antituberculosis Activity in Murine and Rabbit Models of Tuberculosis.吡嗪酸的高全身暴露在结核病小鼠和兔模型中具有有限的抗结核活性。
Antimicrob Agents Chemother. 2016 Jun 20;60(7):4197-205. doi: 10.1128/AAC.03085-15. Print 2016 Jul.
10
Analysis of silibinin in rat plasma and bile for hepatobiliary excretion and oral bioavailability application.大鼠血浆和胆汁中水飞蓟宾的分析及其在肝胆排泄和口服生物利用度方面的应用。
J Pharm Biomed Anal. 2007 Nov 30;45(4):635-41. doi: 10.1016/j.jpba.2007.06.026. Epub 2007 Jul 7.

引用本文的文献

1
Metabolism, Transport and Drug-Drug Interactions of Silymarin.水飞蓟素的代谢、转运和药物相互作用。
Molecules. 2019 Oct 14;24(20):3693. doi: 10.3390/molecules24203693.
2
A significant therapeutic effect of silymarin administered alone, or in combination with chemotherapy, in experimental pulmonary tuberculosis caused by drug-sensitive or drug-resistant strains: In vitro and in vivo studies.水飞蓟素单独或联合化疗对实验性耐多药或敏感肺结核的显著治疗作用:体外和体内研究。
PLoS One. 2019 May 30;14(5):e0217457. doi: 10.1371/journal.pone.0217457. eCollection 2019.
3
Prophylactic Therapy of Silymarin (Milk Thistle) on Antituberculosis Drug-Induced Liver Injury: A Meta-Analysis of Randomized Controlled Trials.
水飞蓟宾(奶蓟草)预防抗结核药物性肝损伤的疗效:一项随机对照试验的荟萃分析。
Can J Gastroenterol Hepatol. 2019 Jan 10;2019:3192351. doi: 10.1155/2019/3192351. eCollection 2019.
4
Pyrazinamide-induced hepatotoxicity and gender differences in rats as revealed by a H NMR based metabolomics approach.基于核磁共振氢谱代谢组学方法揭示的吡嗪酰胺诱导的大鼠肝毒性及性别差异
Toxicol Res (Camb). 2016 Oct 5;6(1):17-29. doi: 10.1039/c6tx00245e. eCollection 2017 Jan 1.
5
Pharmacokinetic interactions of herbal medicines for the treatment of chronic hepatitis.草药治疗慢性肝炎的药代动力学相互作用。
J Food Drug Anal. 2017 Apr;25(2):209-218. doi: 10.1016/j.jfda.2016.11.010. Epub 2016 Dec 22.
6
Herb-drug interactions: challenges and opportunities for improved predictions.中药-药物相互作用:改善预测的挑战与机遇。
Drug Metab Dispos. 2014 Mar;42(3):301-17. doi: 10.1124/dmd.113.055236. Epub 2013 Dec 11.
7
A novel mechanism underlies the hepatotoxicity of pyrazinamide.一种新的机制是吡嗪酰胺肝毒性的基础。
Antimicrob Agents Chemother. 2013 Apr;57(4):1685-90. doi: 10.1128/AAC.01866-12. Epub 2013 Jan 28.
8
Inhibition studies of bovine xanthine oxidase by luteolin, silibinin, quercetin, and curcumin.木犀草素、水飞蓟宾、槲皮素和姜黄素对牛黄嘌呤氧化酶的抑制研究。
J Nat Prod. 2009 Apr;72(4):725-31. doi: 10.1021/np8007123.